Skip to main contentSkip to navigation
Sirius Investors
Omnicell, Inc.

Omnicell, Inc.

OMCL
NASDAQHealthcare

Omnicell, Inc. (OMCL) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Omnicell, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
1015.70
Weak
WeakModerateStrong
P/B Ratio
1.69
Strong
WeakModerateStrong
Earnings Yield
0.10%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
0.17%
Weak
WeakModerateStrong
Operating Margin
0.98%
Weak
WeakModerateStrong
Net Profit Margin
0.17%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
6.53%
Moderate
WeakModerateStrong
Net Income Growth
-83.62%
Weak
WeakModerateStrong
EPS Growth
-83.48%
Weak
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.43
Moderate
WeakModerateStrong
Quick Ratio
1.22
Moderate
WeakModerateStrong
Asset Turnover
0.60x
Moderate
WeakModerateStrong
Inventory Turnover
6.71x
Strong
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
4.17%
Strong
WeakModerateStrong
EV / Free Cash Flow
24.06x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.08x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.971
Strong
WeakModerateStrong
Return on Invested Capital
0.14%
Weak
WeakModerateStrong
Cash Conversion Cycle
97.50 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for OMCL.

View Financial Statements